New Key Statistics Module, Z-Score and F-Score
TSXV:ZYUS Key Ratios
Market Cap C$ M | 72.26 |
Enterprise Value C$ M | 76.22 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.22 |
Price/Sales | 210.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.82 |
Beneish M-Score | -2.58 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.79 |
EV-to-EBITDA | -1.92 |
PEG | -- |
Shares Outstanding M | 70.85 |
Net Margin (%) | -12,915.39 |
Operating Margin % | -4,313.11 |
Pre-tax Margin (%) | -14,581.48 |
Quick Ratio | 0.55 |
Current Ratio | 0.71 |
ROA % (ttm) | -70.15 |
ROE % (ttm) | -180.40 |
ROIC % (ttm) | -23.53 |
Dividend Yield % | -- |
Altman Z-Score | -5.79 |
TSXV:ZYUS Number of Guru Trades
TSXV:ZYUS Volume of Guru Trades
Gurus Latest Trades with TSXV:ZYUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:ZYUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ZYUS Life Sciences Corp Insider Transactions
No Available Data